Allogene Therapeutics, Inc. (ALLO)
NASDAQ·Healthcare·Biotechnology
$1.79
+1.42%
Mkt Cap $607.47M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
Implied Upside
+260.2%
Consensus $6.43 vs current $1.79
NASDAQ·Healthcare·Biotechnology
$1.79
+1.42%
Mkt Cap $607.47M
Buy
4
Hold
1
Sell
0
Price Target (12 analysts)
$6.43
Range $3.85 – $9.00
+260.2%
Consensus $6.43 vs current $1.79